Osteoporosis with pathological fracture (FG)

OSTEOPOROSIS_FRACTURE_FG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints OSTPOPATFRCTURE_POSTEMENO OSTPOPATFRACTURE	2494
6. Filter based on genotype QC (FinnGen only)	2494

Control definitions (FinnGen only)

Control exclude: RHEUMA_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	OSTEOPOROSIS_FRACTURE_FG
CONTROL_EXCLUDE	RHEUMA_ENDPOINTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	OSTPOPATFRCTURE_POSTEMENO\|OSTPOPATFRACTURE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Osteoporosis with pathological fracture (FG) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	21534	20719	796
Only index persons	19400	18718	682
Unadjusted period prevalence (%)
Whole population	0.57	0.59	0.02
Only index persons	0.66	0.69	0.03
Median age at first event (years)
Whole population	78.72	79.16	67.62
Only index persons	78.62	79.02	67.63

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2494	2340	154
Unadjusted period prevalence (%)	0.75	0.80	0.07
Median age at first event (years)	72.85	73.13	68.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2149: Matched controls
21490

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

11.0

323.0

733

969

318

Kela drug reimbursment

Teriparatide

349.3

323.0

325

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

926.5

323.0

1779

111

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

9.4

323.0

1770

7146

M05BA04

ATC

alendronic acid; oral

9.3

323.0

987

1789

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

1411.2

323.0

448

M05BX04

ATC

denosumab; parenteral

17.1

323.0

846

786

H05AA02

ATC

teriparatide; parenteral

392.8

305.7

301

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

24.3

286.8

418

211

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

10.2

279.7

608

797

L95

ICPC

Osteoporosis

13.0

279.3

527

522

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.6

263.7

818

1835

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

18.1

251.1

406

273

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

21.9

244.4

368

201

M81.9

ICD-10 Finland

Osteoporosis, unspecified

9.6

239.7

534

712

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

15.3

235.0

407

323

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

262.3

232.0

234

M17.1

ICD-10 Finland

Other primary gonarthrosis

11.3

225.2

453

495

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.3

213.6

1250

5285

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

760.7

213.5

207

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

22.0

210.8

316

167

N02AX02

ATC

tramadol; systemic, rectal

4.1

199.4

1217

5224

M05BA07

ATC

risedronic acid; oral

9.2

195.4

442

588

P01BA02

ATC

hydroxychloroquine; oral

17.2

194.4

319

216

M54.5

ICD-10 Finland

Low back pain

3.9

181.4

1050

4188

N02AA05

ATC

oxycodone; systemic

5.0

180.2

693

1863

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.5

164.0

423

680

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

19.9

144.7

223

124

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

66.9

144.6

167

H02AB06

ATC

prednisolone; systemic

3.3

144.6

1232

6274

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

26.1

142.9

202

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

8.5

139.9

326

441

M16.1

ICD-10 Finland

Other primary coxarthrosis

17.4

139.0

225

143

NF1AA

NOMESCO Finland

Hip X-ray examination

6.9

137.3

371

627

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

136.6

1259

6673

X59

ICD-10 Finland

Exposure to unspecified factor

4.3

136.2

603

1793

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.8

132.3

708

2482

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

14.3

125.9

221

171

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

152.3

122.6

129

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

7.0

121.7

323

527

N03AX16

ATC

pregabalin; oral

3.4

119.9

751

2941

B01AB05

ATC

enoxaparin; parenteral

3.2

119.4

854

3683

L88

ICPC

Rheumatoid/seropositive arthritis

39.9

117.5

149

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

117.5

1094

5618

L03

ICPC

Low back symptom/complaint

3.2

116.5

790

3263

N03AX12

ATC

gabapentin; oral

4.1

115.6

532

1608

A07EC01

ATC

sulfasalazine; oral, rectal

14.3

113.3

198

151

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

11.9

113.1

216

200

L28

ICPC

Limited function/disability (L)

3.5

113.0

655

2395

L04AX01

ATC

azathioprine; systemic

12.1

111.2

210

190

N02BE01

ATC

paracetamol; systemic, rectal

5.1

108.8

2017

16114

NE1AA

NOMESCO Finland

Pelvis X-ray examination

6.2

106.7

312

575

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

7.0

105.6

278

444

L04AA13

ATC

leflunomide; oral

142.0

102.0

108

N02AJ06

ATC

codeine and paracetamol; systemic

2.8

99.6

858

4064

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

335.0

96.8

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

32.6

95.0

126

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.9

94.1

341

801

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.4

93.0

261

452

C03CA01

ATC

furosemide; systemic

2.6

92.6

1024

5559

A02BC02

ATC

pantoprazole; systemic

2.7

90.8

1597

11161

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

89.6

864

4314

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.1

88.2

585

2293

A28

ICPC

Limited function/disability NOS

2.9

86.6

648

2752

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.6

86.3

890

4592

M48.0

ICD-10 Finland

Spinal stenosis

3.6

86.0

451

1482

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

84.9

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

52.9

84.3

101

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

152.8

83.7

SPAT1229

SPAT

Assessment of need for aid

4.0

82.6

373

1076

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

34.4

82.6

108

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

16.7

82.2

134

M80

ICD-10 Finland

Osteoporosis with pathological fracture

13.8

82.1

145

112

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

81.9

614

2597

WX320

NOMESCO Finland

Spinalanesthesy

3.2

81.8

525

1998

L76

ICPC

Fracture: other

6.7

80.1

217

356

M13.9

ICD-10 Finland

Arthritis, unspecified

10.4

77.6

157

161

M05BA06

ATC

ibandronic acid; systemic

6.5

77.4

213

357

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.8

77.2

367

1103

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

44.6

76.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.9

75.5

270

618

X58

ICD-10 Finland

Exposure to other specified factors

3.8

75.4

363

1101

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

15.1

74.9

127

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

753.5

74.7

SPAT1254

SPAT

Administration of medicine

2.9

72.9

548

2294

H02AB07

ATC

prednisone; oral

3.2

72.7

438

1576

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

22.7

72.5

106

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.3

70.4

1097

6766

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

69.8

674

3257

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

53.9

69.6

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

5.0

68.7

235

511

M79.6

ICD-10 Finland

Pain in limb

2.3

67.8

876

4910

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.6

67.7

256

618

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.9

67.3

492

2010

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

67.0

M35.3

ICD-10 Finland

Polymyalgia rheumatica

9.4

66.6

142

160

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.4

66.3

358

1182

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

668.1

66.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

65.7

787

4233

M01CB01

ATC

sodium aurothiomalate; parenteral

117.0

63.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

62.9

323

1023

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

62.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.9

62.4

453

1830

M81.4

ICD-10 Finland

Drug-induced osteoporosis

46.2

62.1

AA1AD

NOMESCO Finland

CT of head and brain

2.3

61.1

735

3926

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

9.7

60.7

127

138

A06AD11

ATC

lactulose; oral

2.6

60.7

539

2456

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

6.3

60.3

168

284

M05BX03

ATC

strontium ranelate; oral

11.3

59.7

115

107

L02

ICPC

Back symptom/complaint

3.5

59.5

303

950

J01MA02

ATC

ciprofloxacin; systemic

2.2

59.4

938

5668

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

8.0

57.3

134

176

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

+∞

56.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

56.3

377

1438

SPAT1216

SPAT

Assessment of functional ability

2.5

56.0

543

2578

L13

ICPC

Hip symptom/complaint

2.7

55.9

452

1938

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.7

55.5

267

798

W19

ICD-10 Finland

Unspecified fall

3.1

54.7

333

1189

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

53.9

533

2551

ZX120

NOMESCO Finland

Intravenous

3.3

53.5

302

1020

M01AH05

ATC

etoricoxib; oral

2.0

53.5

1113

7435

J01FF01

ATC

clindamycin; systemic

2.3

53.4

621

3223

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

52.9

495

2295

H02AB09

ATC

hydrocortisone; systemic

8.9

52.4

115

136

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

51.4

338

1265

S18

ICPC

Laceration/cut

2.0

51.2

942

5950

L04AA06

ATC

mycophenolic acid; systemic

15.1

51.2

R60.0

ICD-10 Finland

Localized oedema

2.8

50.8

365

1450

H02AB04

ATC

methylprednisolone; systemic

2.7

50.3

398

1673

J01DB01

ATC

cefalexin; oral

2.2

50.3

1707

13717

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

49.6

633

3406

M25.5

ICD-10 Finland

Pain in joint

2.3

49.6

568

2909

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.7

49.4

177

401

L17

ICPC

Foot/toe symptom/complaint

2.2

49.0

650

3556

S22.3

ICD-10 Finland

Fracture of rib

4.1

49.0

203

530

ZXA00

NOMESCO Finland

Right side

2.1

48.7

715

4089

J01MA12

ATC

levofloxacin; systemic

2.5

48.5

458

2124

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

25.0

48.2

NF3AA

NOMESCO Finland

Femur X-ray examination

8.3

47.9

109

137

S52.5

ICD-10 Finland

Fracture of lower end of radius

2.5

46.3

415

1867

A02BC05

ATC

esomeprazole; systemic

2.0

46.1

956

6241

SPAT1263

SPAT

Sampling

1.9

45.8

1005

6696

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

8.2

45.7

105

134

M54.6

ICD-10 Finland

Pain in thoracic spine

3.8

45.1

208

596

R03BB04

ATC

tiotropium bromide; inhalant

3.0

44.5

280

1013

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

44.4

521

2676

S72.0

ICD-10 Finland

Fracture of neck of femur

3.5

44.3

227

708

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.6

44.3

378

1650

N06AX21

ATC

duloxetine; oral

2.9

44.3

292

1090

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.0

43.6

184

488

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

43.2

418

1949

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

24.6

42.5

SPAT1301

SPAT

No procedures

2.0

42.4

816

5131

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.7

42.4

200

584

A01

ICPC

Pain general/multiple sites

3.1

42.0

258

918

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

41.9

393

1801

M54.4

ICD-10 Finland

Lumbago with sciatica

2.5

41.8

383

1733

5BA08

NOMESCO Finland

19.6

41.5

UJF32

NOMESCO Finland

Coloscopy

2.0

41.2

671

3945

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.8

40.8

283

1088

WX002

NOMESCO Finland

Sedation and analgesia

2.2

40.7

483

2478

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.2

40.7

485

2496

S97

ICPC

Chronic ulcer skin

3.7

40.7

191

555

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

40.6

481

2468

WZA00

NOMESCO Finland

Short statement of of health and health related matters

5.8

40.5

119

215

A46

ICD-10 Finland

Erysipelas

2.5

40.5

355

1568

R06.0

ICD-10 Finland

Dyspnoea

2.0

40.2

640

3720

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

45.5

40.1

NF1DA

NOMESCO Finland

X-ray of hips

16.9

40.0

NA2AD

NOMESCO Finland

Thoracic spine CT examination

22.0

39.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.0

39.7

170

456

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

39.6

204

638

M54

ICD-10 Finland

Dorsalgia

2.7

39.3

296

1197

L04AB01

ATC

etanercept; parenteral

394.3

39.2

M81.8

ICD-10 Finland

Other osteoporosis

10.9

38.7

ZXA05

NOMESCO Finland

Left side

2.0

38.4

652

3876

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

38.3

243

881

SPAT1255

SPAT

Intravenous administration of medicine

3.4

38.0

199

630

M01AH02

ATC

rofecoxib; oral

2.4

37.6

372

1744

R50.9

ICD-10 Finland

Fever, unspecified

2.6

37.6

316

1360

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

56.1

37.4

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.4

37.2

116

225

R53

ICD-10 Finland

Malaise and fatigue

2.0

37.1

565

3213

L29

ICPC

Musculoskeletal sympt/complt other

3.0

37.0

226

798

J45.1

ICD-10 Finland

Nonallergic asthma

3.2

37.0

213

720

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

37.0

239

876

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.1

37.0

217

746

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.0

36.7

224

791

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

36.7

395

1928

M01AH01

ATC

celecoxib; oral (coxibs)

2.2

36.7

437

2237

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

16.4

36.5

R03AC02

ATC

salbutamol; inhalant

1.8

36.4

1091

7857

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.5

36.3

314

1370

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

7.3

36.1

127

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

188.1

35.9

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

35.7

287

1202

L04AD01

ATC

ciclosporin; systemic

12.1

35.4

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

5.1

35.3

115

235

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

14.8

35.1

L15

ICPC

Knee symptom/complaint

2.2

35.0

405

2037

R4110

NOMESCO Finland

Physiotherapy

2.0

35.0

602

3571

B01AA03

ATC

warfarin; systemic

2.0

35.0

545

3112

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

35.0

285

1200

M03BX02

ATC

tizanidine; oral

1.8

34.9

1176

8742

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

34.9

963

6725

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

31.3

34.8

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

182.9

34.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

34.8

243

935

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

52.2

34.5

A02BC01

ATC

omeprazole; systemic

1.9

34.4

687

4299

N06AA09

ATC

amitriptyline; systemic

2.5

34.3

309

1375

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

34.3

1122

8246

WZA90

NOMESCO Finland

Other doctors statement

2.1

34.1

433

2272

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.0

33.9

143

378

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

33.8

1038

7468

N30.0

ICD-10 Finland

Acute cystitis

2.1

33.7

471

2569

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

33.5

432

2277

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

33.1

225

850

L86

ICPC

Back syndrome with radiating pain

3.3

33.1

174

552

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

8.5

33.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.0

32.5

204

730

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.3

32.5

103

204

L84

ICPC

Back syndrome without radiat pain

3.6

32.2

151

437

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

32.2

298

1340

SPAT1153

SPAT

Removal of sutures

1.8

32.1

688

4387

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.8

31.6

218

832

A02BC03

ATC

lansoprazole; oral

1.8

31.5

709

4588

S72.1

ICD-10 Finland

Pertrochanteric fracture

4.2

31.5

123

303

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

31.3

746

4919

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

+∞

31.3

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

9.5

30.9

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

30.9

126

323

L04AA01

ATC

[U] ciclosporin; systemic

12.8

30.8

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.5

30.8

150

448

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

30.7

677

4343

J01DA01

ATC

[U] cefalexin; systemic

1.7

30.7

1294

10106

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

30.6

219

854

J46

ICD-10 Finland

Status asthmaticus

4.5

30.5

111

255

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

11.9

30.4

L04AB04

ATC

adalimumab; parenteral

31.3

30.4

E0000UV

ATC

1.7

30.4

859

5957

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

30.3

201

746

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

30.1

520

3062

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

3.1

30.1

173

585

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

29.9

1137

8588

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.0

29.7

185

659

WX110

NOMESCO Finland

Local anesthesy

1.7

29.7

1264

9849

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.4

29.7

150

461

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

11.7

29.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

29.6

242

1018

M09AX01

ATC

hyaluronic acid; parenteral

4.3

29.5

113

273

XG410

NOMESCO Finland

Flow-volume spirometry

4.1

29.5

119

302

J01EA01

ATC

trimethoprim; systemic

1.7

29.5

777

5262

J01FA06

ATC

roxithromycin; oral

1.7

29.4

879

6183

M05BA01

ATC

etidronic acid; systemic

8.3

29.4

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.7

29.3

156

N06AX11

ATC

mirtazapine; oral

1.8

29.3

747

5005

Z01.2

ICD-10 Finland

Dental examination

1.8

29.3

735

4901

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

29.1

286

1323

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.9

29.1

111

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

29.0

118

302

WX212

NOMESCO Finland

Femoral plexus blockade

5.1

28.9

188

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

28.8

394

2116

L75

ICPC

Fracture: femur

6.5

28.8

120

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

7.5

28.8

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

34.2

28.7

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.4

28.7

108

257

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

28.5

207

814

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

28.4

411

2255

WX725

NOMESCO Finland

Noninvasive ventilation

3.7

28.3

130

370

N05CF01

ATC

zopiclone; oral

1.7

28.3

832

5802

C07AB07

ATC

bisoprolol; oral

1.7

28.3

1168

8972

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.2

28.2

153

496

M01AX17

ATC

nimesulide; oral

1.8

28.0

586

3674

A07AA02

ATC

nystatin; oral

2.6

27.9

216

879

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

27.9

128

364

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.2

27.8

157

522

M01AX05

ATC

glucosamine; oral

1.9

27.8

513

3077

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.7

27.8

214

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.7

27.8

208

830

A02BA02

ATC

ranitidine; systemic

1.9

27.8

528

3202

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.4

27.7

138

419

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.8

27.7

120

325

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

27.7

697

4633

R11

ICD-10 Finland

Nausea and vomiting

2.4

27.6

251

1116

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

4.5

27.4

226

NG1DA

NOMESCO Finland

X-ray of knees

21.4

27.4

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

21.4

27.4

B01AF01

ATC

rivaroxaban; oral

2.6

27.3

221

922

C03DA01

ATC

spironolactone; oral

2.2

27.1

305

1503

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

27.1

424

2394

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

27.1

122

342

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

10.8

27.1

NG2AA

NOMESCO Finland

Patella X-ray examination

10.8

27.1

R52.9

ICD-10 Finland

Pain, unspecified

2.6

27.0

213

876

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

4.0

26.7

110

285

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.9

26.4

185

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.5

26.4

221

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.7

26.2

118

331

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.1

26.2

104

261

ZZH31

NOMESCO Finland

Bone allograft, small pieces

18.5

26.1

R03BA05

ATC

fluticasone; inhalant

2.0

26.0

406

2288

R60.9

ICD-10 Finland

Oedema, unspecified

3.1

26.0

148

496

M01AC06

ATC

meloxicam; systemic, rectal

1.7

25.8

763

5294

TGC00

NOMESCO Finland

Bronchial lavation

5.4

25.7

152

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

25.6

239

1077

K59.09

ICD-10 Finland

Constipation, unspecified

2.7

25.5

185

726

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.9

25.4

109

293

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.5

25.3

124

372

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

3.0

25.3

151

523

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

25.3

345

1840

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.8

25.2

112

310

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

25.2

148

505

WX704

NOMESCO Finland

Intubation

2.8

25.1

169

633

NH3EA

NOMESCO Finland

Feet X-ray examination with load

8.8

25.1

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

25.0

273

1322

SPAT1234

SPAT

Support of social functional capacity

2.6

25.0

192

777

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

24.9

268

1289

R06AE07

ATC

cetirizine; oral

1.6

24.9

895

6532

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

24.9

301

1527

SPAT1260

SPAT

Consultation of another employee

1.9

24.9

438

2573

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.1

24.9

141

471

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

24.8

658

4410

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

24.7

225

997

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

91.1

24.7

M81.5

ICD-10 Finland

Idiopathic osteoporosis

6.9

24.7

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.3

24.6

223

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

27.9

24.5

R03AC13

ATC

formoterol; inhalant

3.1

24.4

141

478

A29

ICPC

General symptom/complaint other

2.1

24.4

295

1495

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

24.4

256

1219

A04

ICPC

Weakness/tiredness general

2.0

24.4

356

1951

R03DC03

ATC

montelukast; oral

2.0

24.3

338

1817

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

24.2

405

2334

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.4

24.1

142

127

Kela drug reimbursment

Transplant complication

8.7

24.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.3

24.1

218

M02AA07

ATC

piroxicam; topical

1.6

24.0

881

6448

R03AC12

ATC

salmeterol; inhalant

3.1

24.0

138

467

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

23.9

372

2088

WX111

NOMESCO Finland

Local infiltration anesthesia

68.2

23.8

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.5

23.7

202

864

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.8

23.7

159

593

J01MA14

ATC

moxifloxacin; systemic

2.5

23.7

199

845

M06

ICD-10 Finland

Other rheumatoid arthritis

87.7

23.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.6

23.6

109

312

K02.1

ICD-10 Finland

Caries of dentine

1.6

23.6

928

6904

SPAT1262

SPAT

Handing over of treatment supplies

1.9

23.5

402

2332

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

23.5

243

1148

S70.0

ICD-10 Finland

Contusion of hip

3.3

23.5

125

400

UKC02

NOMESCO Finland

Cystoscopy

2.1

23.4

304

1585

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

11.2

23.4

A41.9

ICD-10 Finland

Sepsis, unspecified

3.7

23.4

106

299

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

23.1

180

733

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

54.6

23.1

R03BB01

ATC

ipratropium bromide; inhalant

3.2

23.0

128

423

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

+∞

23.0

A08

ICPC

Swelling

2.9

22.9

143

511

SPAT1211

SPAT

Application of soft bandage

2.3

22.9

231

1077

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.0

22.8

244

J45.8

ICD-10 Finland

Mixed asthma

4.2

22.8

220

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

22.8

440

2658

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

8.0

22.5

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

22.5

786

5650

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.0

22.3

239

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.3

22.3

118

376

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.1

22.3

128

432

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

22.3

461

2848

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.0

22.3

230

L12

ICPC

Hand/finger symptom/complaint

2.0

22.3

298

1574

N02AC04

ATC

dextropropoxyphene; oral

3.3

22.2

117

372

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

22.1

273

1396

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

22.1

168

676

A01AB09

ATC

miconazole; local oral

2.1

22.1

272

1387

S20.2

ICD-10 Finland

Contusion of thorax

3.2

22.0

119

385

ZZH40

NOMESCO Finland

Substitute of bone

7.5

22.0

J01AA02

ATC

doxycycline; systemic

1.6

22.0

1626

14053

J01CA08

ATC

pivmecillinam; oral

1.6

21.9

1193

9544

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

21.9

241

1170

M02AA10

ATC

ketoprofen; topical

1.9

21.9

382

2227

R02

ICPC

Shortness of breath/dyspnoea

2.0

21.8

302

1615

L08

ICPC

Shoulder symptom/complaint

1.8

21.8

394

2326

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

21.7

163

653

R03BA01

ATC

beclometasone; inhalant

1.9

21.6

331

1842

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

21.6

254

1271

M54.8

ICD-10 Finland

Other dorsalgia

3.3

21.5

110

342

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.9

21.5

133

471

L05

ICPC

Flank/axilla symptom/complaint

2.8

21.4

147

557

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

21.4

633

4338

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.8

21.3

142

529

B01AX06

ATC

[U] rivaroxaban; oral

19.1

21.3

U04

ICPC

Incontinence urine

2.6

21.2

159

633

P01AB01

ATC

metronidazole; oral, rectal

1.6

21.2

812

5952

M01AE02

ATC

naproxen; oral, rectal

1.5

20.9

1020

7916

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

20.9

R03DA04

ATC

theophylline; systemic, rectal

2.7

20.8

147

567

-50

ICPC

Medication/prescr/renewal

3.0

20.7

124

430

L99

ICPC

Musculoskeletal disease other

5.2

20.6

125

XW000

NOMESCO Finland

Bone marrow biopsy

3.3

20.6

107

337

SPAT1325

SPAT

Vaccination

1.6

20.5

822

6077

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

20.4

833

6181

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

18.5

20.4

WZC30

NOMESCO Finland

Teaching

2.0

20.4

274

1445

H26.3

ICD-10 Finland

Drug-induced cataract

14.4

20.3

SPAT1210

SPAT

Application of cast or individual aid

2.9

20.3

129

466

N05BA01

ATC

diazepam; systemic, rectal

1.9

20.3

338

1934

Z50.1

ICD-10 Finland

Other physical therapy

2.8

20.2

132

486

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.3

20.2

105

331

R96

ICPC

Asthma

2.2

20.1

226

1107

R03BA02

ATC

budesonide; inhalant

1.8

20.0

378

2258

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

17.5

20.0

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

6.0

20.0

ZX140

NOMESCO Finland

Intra articular

58.1

19.9

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

58.1

19.9

Y94.0

ICD-10 Finland

Accident at home

4.4

19.9

171

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.6

19.8

260

S32.5

ICD-10 Finland

Fracture of pubis

5.7

19.8

102

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

19.7

640

4474

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.7

19.7

141

549

L11

ICPC

Wrist symptom/complaint

2.3

19.7

183

821

M40.1

ICD-10 Finland

Other secondary kyphosis

29.2

19.6

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

201.7

19.6

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.6

19.6

149

598

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

12.2

19.6

L16

ICPC

Ankle symptom/complaint

2.2

19.5

209

1001

M17.5

ICD-10 Finland

Other secondary gonarthrosis

24.8

19.5

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.4

19.5

L90

ICPC

Osteoarthrosis of knee

3.3

19.5

101

318

R51.80

ICD-10 Finland

Headache

2.0

19.4

288

1577

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

19.4

381

2302

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

19.4

143

566

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.8

19.4

126

461

SPAT1310

SPAT

Counselling related to known health issue

1.6

19.4

679

4839

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

19.4

126

462

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.2

19.3

105

342

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

19.3

146

587

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

3.6

19.3

256

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

4.8

19.2

140

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.0

19.2

111

377

M01CB03

ATC

auranofin; oral

46.4

19.2

JN4BD

NOMESCO Finland

Extensive body CT

2.0

19.2

269

1442

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

228

62.63

307.65

1.9

1.4

ug/l

0.3

0.6

2.10

143

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1988

9245

6.67

307.65

4.3

2.1

nmol/l

86.2

81.6

10.48

1814

7923

(3004588) Protein electrophoresis panel - Serum or Plasma

620

1296

6.04

294.03

2.0

2.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

747

1879

5.25

286.94

3.0

3.1

ng/l

72.8

86.2

4.76

610

1527

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2090

11631

5.92

273.34

11.5

5.7

mmol/l

1.2

0.45

1734

9621

(3003458) Phosphate [Moles/volume] in Serum or Plasma

866

2559

4.65

270.82

4.7

4.3

mmol/l

1.0

1.69

758

2289

(3020630) Protein [Mass/volume] in Serum or Plasma

667

1625

5.24

264.18

2.1

2.8

g/l

65.8

65.6

0.27

550

1408

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1913

10532

4.50

237.40

9.9

5.0

mmol/l

1.2

0.76

1760

9258

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

117

51.10

202.94

1.9

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

594

1646

4.42

195.71

2.4

2.2

nmol/l

309.1

403.3

13.72

549

1466

(42870588) Differential panel, method unspecified - Blood

1271

6066

3.23

179.60

9.4

4.2

—

(3013115) Eosinophils [#/volume] in Blood

1643

9177

3.32

175.62

10.3

4.3

e9/l

0.2

5.69

1452

7687

(3018418) pH of Serum or Plasma

1391

7064

3.19

175.26

6.3

3.6

7.4

0.79

312

1223

(3001604) Monocytes [#/volume] in Blood

1600

8813

3.28

174.90

9.9

4.1

e9/l

0.6

1.28

1415

7231

(3006315) Basophils [#/volume] in Blood

1604

8867

3.27

173.85

9.9

4.1

e9/l

0.0

1.35

1422

7288

(3022096) Basophils/100 leukocytes in Blood

1500

8065

3.16

168.91

10.5

4.3

0.6

0.7

2.51

1390

7305

(3019198) Lymphocytes [#/volume] in Blood

1614

9077

3.21

167.31

10.1

4.2

e9/l

1.7

1.9

7.81

1435

7630

(3019069) Monocytes/100 leukocytes in Blood

1531

8360

3.15

167.11

10.9

4.5

8.8

8.7

0.38

1421

7589

(3006504) Eosinophils/100 leukocytes in Blood

1525

8314

3.15

166.82

10.4

4.3

2.5

2.8

5.53

1409

7521

(3034860) Kappa light chains.free [Mass/volume] in Serum

326

621

5.89

166.25

2.2

3.3

mg/l

53.3

143.6

0.50

239

516

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

325

622

5.86

164.88

2.2

3.3

mg/l

26.0

44.6

2.35

238

517

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

938

3931

3.22

162.20

1.4

1.2

u/ml

1.0

1.6

1.15

256

945

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

316

602

5.87

160.98

2.2

3.3

ratio

1.3

2.0

0.83

(3002030) Lymphocytes/100 leukocytes in Blood

1539

8553

3.09

160.39

10.7

4.5

23.9

27.2

24.14

1420

7711

(3018010) Neutrophils/100 leukocytes in Blood

1520

8400

3.07

159.82

10.0

4.3

61.1

57.8

18.64

1408

7622

(3024561) Albumin [Mass/volume] in Serum or Plasma

1673

9816

3.14

156.73

7.1

4.1

g/l

33.5

34.9

18.44

1544

8920

(3023368) Bacteria identified in Blood by Culture

1154

5550

3.01

155.04

5.7

3.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

257

447

6.30

143.45

2.2

3.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1764

10984

3.07

142.24

13.2

7.8

e9/l

4.5

4.1

8.54

1577

9307

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1088

5306

2.86

138.81

3.0

2.2

mg/l

3.5

3.1

3.04

937

4393

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

822

3496

3.02

134.37

2.4

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

383

1032

4.20

127.66

3.7

2.7

g/l

9.2

10.5

5.83

351

911

(3044927) Protein electrophoresis panel - Urine

156

177

9.33

126.73

1.2

—

(3032080) INR in Blood by Coagulation assay

1458

8578

2.68

124.16

16.2

9.4

inr

1.3

0.74

391

2304

(3013707) Erythrocyte sedimentation rate by Westergren method

2056

14504

3.38

122.58

8.1

3.1

mm/h

18.1

14.5

16.61

1910

12852

(3015377) Calcium [Moles/volume] in Serum or Plasma

1417

8282

2.65

121.31

3.9

3.4

mmol/l

2.4

3.81

1190

6959

(3007164) IgA [Mass/volume] in Serum or Plasma

752

3198

2.93

121.13

1.8

1.4

g/l

2.6

2.5

0.46

435

1612

(3042936) Bacteria identified in Isolate by Culture

601

2284

3.15

117.89

2.8

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2184

16128

3.85

117.60

13.3

6.6

u/l

80.9

81.6

0.18

2084

14768

(3027945) Reticulocytes/100 erythrocytes in Blood

596

2260

3.15

117.30

2.7

2.1

2.0

1.9

0.96

518

1958

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

138

150

9.68

115.71

1.7

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

305

746

4.52

114.96

1.9

2.4

g/l

3.6

0.04

205

496

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

305

746

4.52

114.96

1.9

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

305

747

4.51

114.76

1.9

2.4

g/l

7.7

7.3

2.29

211

522

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1402

8387

2.53

110.67

5.6

3.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

285

683

4.58

110.09

1.8

2.5

g/l

3.1

3.0

0.18

206

507

(3022948) Iron [Moles/volume] in Serum or Plasma

707

3042

2.85

110.00

2.9

2.2

umol/l

10.3

12.0

7.63

646

2740

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

710

4.51

109.87

1.9

2.4

g/l

9.7

10.3

0.94

221

566

(3004789) Transferrin [Mass/volume] in Serum or Plasma

664

2781

2.89

108.49

2.8

2.2

g/l

2.3

0.73

604

2500

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

637

2614

2.93

108.03

2.9

2.3

19.2

20.4

1.17

493

2181

(3037756) Immunofixation for Serum or Plasma

213

404

5.67

108.02

1.4

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

122

129

9.89

104.32

2.1

1.1

e6/l

17767.1

9684.9

0.59

(3028026) IgM [Mass/volume] in Serum or Plasma

313

844

4.10

103.34

2.0

1.7

g/l

1.3

1.5

1.04

282

731

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1300

7690

2.44

102.53

3.8

2.6

ug/l

129.3

123.1

0.28

1175

6855

(3023520) Reticulocytes [#/volume] in Blood

471

1677

3.23

101.96

3.1

2.3

e9/l

72.6

69.7

0.78

380

1242

(3007853) Bacteria identified in Skin by Aerobe culture

531

2037

3.04

101.03

2.4

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

476

1718

3.19

100.62

1.6

1.2

titre

721.8

430.2

2.41

130

340

(3026008) Bacteria identified in Urine by Culture

1397

8602

2.42

99.69

5.4

3.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1656

11032

2.49

98.53

8.3

5.8

umol/l

11.5

0.03

1569

10347

(3031040) Bacteria [#/volume] in Urine by Automated count

1976

14324

2.83

98.23

8.9

5.1

e6/l

1533.4

4145.4

1.81

203

(3012095) Magnesium [Moles/volume] in Serum or Plasma

741

3447

2.64

97.26

4.1

2.8

mmol/l

0.8

3.66

667

3138

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

546

2231

2.85

91.81

4.0

3.9

u/l

256.5

249.1

0.54

505

2081

(3037467) Urinalysis macro (dipstick) panel - Urine

1939

14143

2.67

91.06

8.2

4.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

579

2457

2.77

90.45

2.2

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1747

12167

2.46

90.28

7.4

4.1

mmol/l

6.6

6.8

7.18

1693

11332

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

241

592

4.40

89.72

1.7

2.2

g/l

37.6

0.02

184

470

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

248

626

4.29

89.09

1.8

2.4

g/l

0.5

1.1

1.64

193

511

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1126

6543

2.31

88.64

2.6

2.0

u/l

153.2

194.4

1.75

1043

6041

(3019309) Folate [Moles/volume] in Red Blood Cells

907

4842

2.37

86.59

2.0

1.8

nmol/l

1217.9

1193.8

0.31

664

3481

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

570

2454

2.71

86.14

2.2

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

189

394

5.11

85.94

1.9

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1110

6496

2.28

84.92

3.5

2.4

u/l

58.4

59.3

0.15

1026

5873

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

260

736

3.83

79.52

2.2

1.8

ug/l

1.7

0.01

230

625

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

144

252

6.00

79.18

1.7

1.6

iu/ml

0.1

0.3

0.39

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

162

323

5.29

77.39

2.3

1.2

g/l

0.2

0.96

150

302

(3017181) Myelocytes/100 leukocytes in Blood

388

1436

3.02

77.20

5.0

3.3

0.9

0.02

139

404

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1177

7270

2.17

76.40

5.1

3.0

—

(3037121) Protein [Mass/volume] in Urine

239

657

3.92

76.13

2.4

2.8

g/l

0.3

0.2

0.29

215

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

163

333

5.17

75.73

2.2

1.2

g/l

1.1

1.2

1.38

155

312

(36660697) Celiac disease serology panel - Serum

380

1406

3.01

75.56

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

363

1310

3.07

75.41

4.8

3.2

0.5

0.6

0.53

108

289

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1146

7034

2.16

75.28

4.0

2.9

ng/l

1562.6

1633.3

0.28

989

6019

(3021960) Folate [Moles/volume] in Serum or Plasma

964

5561

2.20

73.82

1.8

1.5

nmol/l

22.1

21.4

0.51

803

4595

(3021788) Differential panel - Synovial fluid

10.43

73.46

1.9

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

1027

6083

2.17

73.44

3.3

2.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

208

533

4.17

72.93

1.7

2.4

g/l

0.0

0.1

1.24

180

469

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

467

1966

2.69

72.67

2.5

1.9

g/l

0.2

2.20

417

1821

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

14.02

72.58

1.8

1.2

64.6

59.5

0.26

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

200

505

4.22

71.49

1.7

2.4

g/l

0.0

0.39

172

445

(3026782) Osmolality of Urine

781

4190

2.26

71.05

4.0

2.7

mosm/kgh2o

483.9

512.4

3.51

675

3485

(3025159) Blasts/100 leukocytes in Blood

348

1267

3.03

70.97

5.1

3.3

0.8

0.4

0.22

117

318

(3021440) Promyelocytes/100 leukocytes in Blood

365

1366

2.96

70.86

5.1

3.4

0.1

0.18

135

374

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

196

498

4.19

69.45

1.7

2.4

g/l

0.0

0.00

172

444

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

418

1704

2.75

69.04

2.1

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1297

8554

2.08

68.25

5.9

3.9

ng/l

32.7

46.3

1.97

1051

6344

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

181

445

4.31

66.95

1.8

1.4

titre

107.3

267.1

0.41

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

271

886

3.31

66.13

2.0

1.6

g/l

1.6

1.5

0.77

238

753

(3019060) Gas panel - Arterial blood

351

1355

2.85

64.04

5.5

4.2

—

(3044941) Cell count panel - Synovial fluid

9.53

63.85

1.7

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

656

3419

2.25

62.85

7.9

3.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

387

1592

2.69

62.39

8.1

5.8

mmol/l

10.6

10.3

0.25

367

1494

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

801

4531

2.13

62.31

3.2

2.2

—

(3000850) Epithelial cells [#/volume] in Urine

757

4208

2.15

61.48

3.8

2.4

e6/l

6.3

7.2

1.25

689

3604

(3003396) Base excess in Arterial blood by calculation

499

2339

2.42

61.05

7.6

5.5

mmol/l

2.1

1.3

3.03

411

1836

(3002582) Erythrocytes [#/volume] in Urine

994

6129

2.03

60.95

4.8

3.0

e6/l

37.6

76.4

1.58

810

4495

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

305

1126

2.95

60.24

5.3

3.3

kpa

5.3

5.2

0.58

281

1051

(3009343) pH of Capillary blood

303

1115

2.96

60.20

5.3

3.3

7.4

0.29

152

(3026493) Urate [Moles/volume] in Serum or Plasma

739

4104

2.14

59.91

3.2

2.4

umol/l

4975.8

8831.2

1.26

619

3372

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1391

9708

1.98

59.18

2.5

2.0

pmol/l

97.0

96.1

0.25

700

4404

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

147

339

4.55

58.93

2.2

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

293

1084

2.93

57.55

5.2

3.2

mmol/l

2.5

2.3

0.39

229

834

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

722

4032

2.11

57.27

2.1

1.7

mg/l

1.5

1.3

0.48

581

3071

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

490

2340

2.36

57.13

7.6

5.5

kpa

5.2

5.1

1.35

461

2216

(3027801) Oxygen [Partial pressure] in Arterial blood

489

2339

2.36

56.77

7.6

5.5

kpa

11.4

12.2

2.50

460

2216

(3003181) Sodium [Moles/volume] in Urine

182

506

3.80

56.73

1.6

1.3

mmol/l

64.7

57.0

1.42

138

386

(3016502) Oxygen saturation in Arterial blood

440

2019

2.43

56.04

7.8

5.9

95.3

95.4

0.10

420

1942

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1536

11219

1.96

55.71

4.7

2.9

u/l

66.8

49.3

3.68

1410

9978

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

312

1219

2.78

55.27

1.7

1.5

—

(3019225) pH of Specimen

483

2324

2.34

55.18

8.7

4.1

—

(3017704) Immunofixation for Urine

8.14

54.26

1.4

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

108

207

5.41

53.77

1.7

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

923

5738

1.97

53.62

4.7

2.9

e6/l

0.4

0.5

0.97

751

4207

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

463

2231

2.32

52.49

1.4

1.2

u/ml

27.1

2.9

4.65

155

758

(3018095) Leukocytes [#/volume] in Urine

1093

7249

1.90

51.81

5.6

3.5

e6/l

96.5

156.9

2.20

845

4880

(3015171) Extractable nuclear Ab [Units/volume] in Serum

171

489

3.68

51.09

1.4

1.1

u/ml

0.8

0.01

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

120

264

4.72

50.94

5.3

3.2

60.5

58.9

0.48

120

264

(36304419) Bacteria [Presence] in Urine

890

5546

1.94

50.70

4.7

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

1378

9934

1.87

49.45

6.6

4.1

estimate

0.0

0.00

296

1659

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

484

2431

2.23

49.42

1.4

1.2

iu/ml

38.4

22.3

1.93

177

678

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

113

243

4.82

49.29

6.6

4.8

iu/ml

1416.5

569.7

0.45

(3010144) Erythrocytes [#/volume] in Synovial fluid

10.81

48.92

1.7

1.0

e6/l

89133.0

200669.4

0.35

(3009261) Glucose [Presence] in Urine by Test strip

1394

10114

1.86

48.71

6.7

4.1

estimate

0.0

1.08

304

1646

(3021601) Nitrite [Presence] in Urine by Test strip

1382

10021

1.85

48.16

8.6

5.6

estimate

0.0

0.00

293

1612

(3047181) Lactate [Moles/volume] in Blood

190

610

3.29

47.39

7.3

5.5

mmol/l

1.2

1.3

0.10

175

534

(3024980) IgG subclass 4 [Mass/volume] in Serum

199

5.14

46.71

1.8

1.5

g/l

0.8

0.7

0.24

155

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2273

19706

2.73

46.53

34.7

13.8

mg/l

23.9

25.4

1.58

2064

15281

(3002173) Hemoglobin [Mass/volume] in Arterial blood

402

1915

2.31

46.38

8.3

6.1

g/l

114.3

118.6

4.80

386

1839

(4062490)

123

6.43

46.27

1.6

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

121

6.45

45.81

1.6

1.2

g/l

6.1

7.5

1.29

(3028192) IgG subclass 2 [Mass/volume] in Serum

121

6.45

45.81

1.6

1.2

g/l

2.1

2.8

2.73

(3024139) IgG subclass 3 [Mass/volume] in Serum

121

6.45

45.81

1.6

1.2

g/l

0.3

0.4

1.77

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

12.00

45.50

1.8

1.2

24.3

45.2

1.54

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

155

457

3.55

44.17

1.6

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

139

381

3.80

44.11

1.7

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

271

1112

2.61

43.18

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

303

1316

2.48

42.85

8.1

5.9

mmol/l

25.5

24.8

2.46

285

1226

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

195

4.97

42.77

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

296

1277

2.50

42.45

1.6

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

192

662

3.06

42.41

2.8

2.0

ug/l

314.1

806.4

0.93

176

626

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

256

1032

2.65

42.24

9.7

7.5

—

(3011412) CD3 cells [#/volume] in Blood

120

6.15

41.49

2.3

1.8

e9/l

1.1

0.01

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

779

4900

1.86

41.35

3.5

3.1

mmol/l

2.5

0.86

686

4251

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

409

2051

2.19

41.33

4.5

2.9

ng/l

224.7

231.2

0.11

383

1876

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1260

9142

1.76

41.31

2.8

2.3

—

(3018572) Chloride [Moles/volume] in Blood

149

449

3.47

41.04

7.4

6.0

mmol/l

104.2

104.8

0.71

139

402

(3039000) Anion gap in Blood

149

449

3.47

41.04

7.4

6.0

mmol/l

10.6

11.1

0.99

139

402

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

400

1998

2.19

40.78

6.2

3.3

mmol/l

1.2

0.00

379

1645

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

125

336

3.86

40.77

1.4

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1958

16251

1.95

40.40

5.4

4.4

pmol/l

15.5

15.1

6.68

1755

14353

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

206

759

2.87

40.37

1.4

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

276

1188

2.49

39.67

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

369

3.66

39.19

1.7

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

562

3226

1.96

39.16

2.5

2.0

29.6

0.09

541

3126

(3000494) Fungus identified in Specimen by Culture

401

2038

2.15

39.01

1.9

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

865

5708

1.79

38.68

5.4

3.0

u/l

32.0

36.1

0.99

805

5299

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

178

623

3.00

38.24

3.2

2.8

—

(40768797) Stomach Pathology biopsy report

487

2713

1.99

36.77

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

8.82

36.69

35.4

29.4

ug/l

114.3

106.4

0.31

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

701

4404

1.82

36.55

5.9

3.7

ng/l

314.5

220.5

0.37

616

3659

(3023419) Bacteria identified in Sputum by Culture

222

4.36

36.50

2.7

2.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

178

4.79

36.31

9.8

5.3

mg/l

12.8

13.1

0.16

163

(3021879) Hepatitis B virus core Ab [Presence] in Serum

184

687

2.81

35.10

1.4

1.3

—

(3022313) Gas panel - Capillary blood

203

799

2.68

34.98

5.8

3.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.36

34.72

2.1

1.7

—

(3017732) Neutrophils [#/volume] in Blood

248

1080

2.44

34.61

3.8

2.7

e9/l

4.3

4.2

0.17

158

767

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

102

267

3.94

34.52

1.3

1.1

u/ml

9.8

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2168

18944

2.10

34.47

6.8

5.3

mu/l

2.0

2.2

1.00

1965

16819

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

224

933

2.54

34.38

6.4

4.2

1.8

1.5

3.26

210

876

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

112

314

3.69

34.37

1.4

1.1

u/ml

5.2

5.4

0.02

(1616796) Gas panel - Central venous blood

132

412

3.33

34.36

4.4

2.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

172

630

2.86

33.99

2.7

2.0

u/l

41.4

40.3

0.23

136

541

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

262

3.93

33.81

1.6

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

112

318

3.64

33.74

1.4

1.1

u/ml

21.0

4.5

0.92

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

118

347

3.52

33.72

1.4

1.1

u/ml

45.5

22.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

194

4.45

33.56

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

182

693

2.75

33.43

6.2

3.6

mmol/l

25.3

25.1

0.33

164

623

(3007930) Methemoglobin/Hemoglobin.total in Blood

222

939

2.50

32.96

6.4

4.2

1.0

0.9

1.94

210

884

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

5.97

32.63

2.0

1.7

16.7

10.5

1.89

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

220

4.16

32.56

1.5

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

774

5145

1.73

32.55

5.9

3.5

88.9

89.3

0.17

749

5001

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

291

1398

2.22

32.27

1.9

1.7

—

(3012501) Base excess in Blood by calculation

132

429

3.19

32.16

5.5

3.3

mmol/l

3.3

2.9

0.73

105

304

(3002032) Base excess in Venous blood by calculation

391

2107

2.01

32.08

5.5

3.2

mmol/l

3.0

2.0

4.36

323

1743

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

204

841

2.55

31.95

2.6

1.8

—

(3010421) pH of Blood

149

523

2.97

31.80

5.4

3.1

7.4

0.01

130

413

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

138

467

3.07

31.40

2.3

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

390

2122

1.99

31.07

5.5

3.1

kpa

6.0

5.8

3.17

373

2067

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

124

397

3.23

30.97

2.9

2.1

mg/l

10.8

12.7

1.26

100

366

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

576

3563

1.80

30.84

3.7

2.5

e6/l

1.4

2.3

0.58

341

1940

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

102

289

3.64

30.82

1.7

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

191

778

2.58

30.65

2.5

1.7

—

(3008295) Osmolality of Serum or Plasma

226

4.00

30.59

1.4

1.2

mosm/kgh2o

266.8

273.0

1.27

161

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

200

4.21

30.55

2.4

2.5

u/ml

196.5

1668.3

—

(3000991) Gas panel - Venous blood

330

1703

2.08

30.38

9.0

6.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

134

457

3.04

30.08

3.9

2.6

mmol/l

26.0

25.6

0.45

125

415

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

383

2095

1.98

29.98

5.9

3.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

400

2222

1.95

29.93

3.6

2.4

umol/l

11.3

9.2

0.46

328

1865

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

154

4.65

29.71

1.5

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

890

6262

1.66

29.62

3.4

2.9

mmol/l

5.5

6.0

5.13

753

5104

(3014576) Chloride [Moles/volume] in Serum or Plasma

456

2672

1.86

28.92

8.3

5.3

mmol/l

102.8

104.0

4.54

440

2625

(3005322) IgE [Units/volume] in Serum or Plasma

205

891

2.42

28.61

1.6

1.2

u/ml

199.0

136.9

0.67

191

813

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

6.58

28.56

2.4

1.8

e6/l

495.3

503.5

0.03

(3004809) Band form neutrophils/100 leukocytes in Blood

100

295

3.49

28.44

3.1

3.5

1.1

1.4

0.39

226

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

216

3.94

28.34

1.2

1.1

u/l

67.3

54.8

1.07

146

(40767503) Oxygen content in Capillary blood by calculation

123

415

3.07

28.13

3.3

2.3

14.5

15.9

3.58

211

(21494815) CD4 cells/100 lymphocytes in Specimen

5.56

27.75

1.9

2.0

34.5

46.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

340

1841

1.98

27.24

7.8

4.9

mmol/l

1.4

0.28

325

1769

(3035637) Corticotropin [Mass/volume] in Plasma

227

3.79

27.21

1.2

1.4

—

(3016038) Potassium [Moles/volume] in Urine

166

4.31

27.06

1.2

1.1

mmol/l

29.7

33.2

0.65

135

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

6.47

26.92

2.4

1.8

e9/l

0.2

0.66

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

6.38

26.55

1.7

nmol/l

3.8

7.2

0.48

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

105

5.23

26.48

2.1

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

162

659

2.56

26.02

3.6

3.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

211

3.83

26.02

1.6

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1022

7627

1.58

25.68

7.7

4.5

—

(3021589) Normoblasts [#/volume] in Blood

1107

8415

1.57

25.65

19.7

8.4

e9/l

0.0

0.40

937

6665

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

165

683

2.52

25.56

4.4

3.0

u/ml

0.3

0.4

0.19

110

404

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

248

1225

2.14

25.45

2.8

3.0

pmol/l

4.2

4.4

2.61

193

1063

(3042631) Mycobacterium sp identified in Specimen

253

3.53

25.31

2.7

3.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

521

3297

1.73

25.16

4.0

2.6

e6/l

3.5

4.5

1.21

286

1693

(3006184) Hemoglobin [Mass/volume] in Capillary blood

123

442

2.88

25.15

2.4

2.0

g/l

117.4

125.5

3.22

322

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

731

5086

1.62

24.43

1.9

1.7

pmol/l

44295785.3

22586025.3

0.38

596

3945

(40758558) Short blood count panel - Blood

722

5009

1.62

24.41

9.9

6.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

250

3.48

24.31

1.4

1.1

u/ml

62.6

27.0

1.23

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

116

412

2.90

24.23

4.0

2.7

mg/l

1.7

1.6

1.21

109

365

(21494890) Protein electrophoresis panel - 24 hour Urine

185

3.92

24.22

1.6

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

720

5001

1.62

24.19

6.4

3.9

—

(3048689) Calprotectin [Mass/mass] in Stool

353

2016

1.87

23.94

2.7

1.9

ug/g

235.4

148.6

1.93

279

1492

(40761511) CBC panel - Blood by Automated count

2236

20359

1.95

22.80

31.8

13.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

198

3.71

22.77

3.0

4.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

487

3104

1.71

22.67

34.8

28.0

inr

1.4

1.5

0.37

347

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

111

405

2.82

22.08

1.6

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

754

5389

1.57

22.06

8.0

4.5

estimate

0.0

0.50

291

1593

(3039162) Centromere protein B Ab [Units/volume] in Serum

153

4.06

21.94

1.4

1.1

u/ml

50.0

0.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2299

21186

2.09

21.87

38.3

17.6

mmol/l

138.6

139.6

36.12

2258

20463

(3034891) Synovial lining cells/100 cells in Synovial fluid

11.05

21.56

1.7

1.3

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2300

21224

2.08

21.39

38.4

17.7

mmol/l

4.0

0.07

2256

20461

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

232

3.39

21.24

1.8

1.4

—

(3014271) Vancomycin [Susceptibility]

141

4.11

20.90

4.0

2.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

11.76

20.47

1.7

1.8

—

(3025941) Bacteria identified in Stool by Culture

201

995

2.11

20.42

1.4

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

312

1801

1.84

20.29

5.2

2.8

kpa

4.5

4.4

0.30

296

1748

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

13.67

20.23

1.6

1.1

33.3

32.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

124

501

2.55

20.20

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

124

501

2.55

20.20

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

341

2032

1.79

19.94

3.0

2.5

ug/l

6.0

5.9

0.04

260

1674

(3019150) Specific gravity of Urine by Refractometry

645

4537

1.57

19.87

7.5

4.6

kg/l

1.0

1.18

101

731

(3009214) Lutropin [Units/volume] in Serum or Plasma

148

3.92

19.58

1.2

u/l

19.6

21.5

0.25

119

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

195

975

2.08

19.29

5.8

3.4

mmol/l

24.7

24.2

0.93

173

876

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

198

998

2.07

19.17

8.6

6.9

mmol/l

25.2

24.4

1.59

185

928

(3004119) Hemoglobin [Mass/volume] in Venous blood

259

1441

1.89

18.87

5.5

2.8

g/l

121.4

126.9

4.24

253

1409

(3021901) Oxygen saturation in Capillary blood

353

2.79

18.85

3.2

2.4

—

(4010399)

256

1421

1.89

18.78

1.7

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

145

653

2.30

18.62

1.6

1.4

ug/g

253.6

269.4

0.43

385

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

115

467

2.53

18.55

4.3

2.4

g/l

3.4

3.6

0.49

108

440

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

110

4.34

18.54

1.1

1.2

u/ml

0.3

1.2

0.57

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

102

4.47

18.48

1.2

1.1

u/l

42.2

30.6

0.24

(3017354) Segmented neutrophils/100 leukocytes in Blood

169

3.61

18.37

2.9

3.5

64.9

59.3

1.06

112

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

103

4.43

18.26

1.2

1.1

u/l

115.8

92.3

0.33

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

152

3.75

18.09

1.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

112

456

2.52

17.98

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.55

17.90

3.9

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

274

2.98

17.88

1.4

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

5.36

17.78

2.5

2.1

e6/l

510.9

695.8

0.73

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

164

3.60

17.66

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1936

17263

1.54

17.53

34.1

16.1

36.5

37.8

4.94

1032

10735

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

139

3.80

17.18

1.3

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

139

3.80

17.18

1.3

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

139

3.80

17.18

1.3

1.4

—

(3013512) EKG study

857

6564

1.47

17.09

5.4

4.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

309

2.81

17.07

1.5

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

149

3.68

17.05

1.4

1.2

—

(3024263) Appearance of Synovial fluid

6.90

16.98

2.8

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

344

2.71

16.97

3.7

2.3

umol/l

35.1

33.0

0.33

288

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

189

3.34

16.84

2.0

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2268

21096

1.83

16.64

18.7

9.7

u/l

22.2

22.9

1.36

2181

19924

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

5.61

16.02

3.3

2.1

40.8

42.8

0.17

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

4.78

15.65

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

4.78

15.65

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

4.78

15.65

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

4.78

15.65

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

183

3.28

15.61

3.6

3.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

184

3.26

15.48

1.2

u/ml

262.6

248.8

0.16

107

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

205

1132

1.88

15.23

5.0

2.3

1.2

1.1

1.42

205

1125

(44806118)

161

3.41

15.21

1.8

1.2

—

(44790048)

161

3.41

15.21

1.8

1.2

—

(44790049)

161

3.41

15.21

1.8

1.2

—

(44790047)

161

3.41

15.21

1.8

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.55

15.18

1.3

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.55

15.18

1.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.55

15.18

1.3

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.55

15.18

1.3

1.6

—

(3036603) Volume of Urine

128

3.72

15.15

1.4

1985.1

1824.8

0.32

(3034770) Mitochondria Ab [Titer] in Serum

401

2.48

15.11

1.3

1.1

titre

1184.0

779.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.13

15.05

2.0

1.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2046

18660

1.54

14.78

6.4

6.1

mmol/mol

39.8

40.6

3.64

1798

16560

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.54

14.78

2.1

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

218

1241

1.83

14.70

2.6

2.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

4.64

14.70

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

4.64

14.70

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2313

21764

1.86

14.65

48.3

21.1

e9/l

7.1

6.7

14.23

2260

20795

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

199

1103

1.87

14.61

5.0

2.3

0.7

0.07

194

1056

(3007461) Platelets [#/volume] in Blood

2312

21755

1.86

14.59

48.2

21.1

e9/l

261.2

252.7

6.45

2263

20879

(3024731) MCV [Entitic volume]

2312

21757

1.86

14.56

48.1

21.0

92.4

91.4

17.25

2280

21194

(3026361) Erythrocytes [#/volume] in Blood

2312

21760

1.86

14.51

48.3

21.1

e12/l

4.1

4.3

73.92

2261

20793

(3035941) MCH [Entitic mass]

2312

21760

1.86

14.51

48.0

21.0

30.3

30.2

1.54

2280

21198

(3000963) Hemoglobin [Mass/volume] in Blood

2312

21766

1.85

14.41

48.6

21.2

g/l

124.3

130.5

87.99

2281

21212

(3000492) Spirometry study

237

1392

1.78

14.40

1.7

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

152

3.40

14.39

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

322

2.60

14.23

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

4.97

14.05

2.2

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

201

3.03

14.00

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

273

2.72

13.95

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

108

486

2.28

13.93

3.3

2.2

91.2

90.9

0.04

103

449

(3027273) Bicarbonate [Moles/volume] in Venous blood

210

1210

1.80

13.60

5.0

2.9

mmol/l

26.2

25.4

2.40

203

1184

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.07

13.55

1.8

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

227

2.87

13.51

2.4

2.0

nmol/l

9.9

11.6

0.94

191

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

209

1206

1.80

13.47

2.0

1.6

1.4

2.32

166

1012

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

144

3.38

13.43

1.8

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

140

3.40

13.29

1.4

1.5

u/l

12.9

5.5

0.46

(3007566) Smooth muscle Ab [Titer] in Serum

383

2.40

13.20

1.3

1.1

titre

131.0

127.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

109

504

2.22

13.19

1.8

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.98

13.17

1.8

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

659

4998

1.43

13.15

6.3

4.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

109

507

2.20

13.00

1.9

1.6

iu/l

4.5

4.1

0.14

162

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

104

3.79

12.99

2.3

2.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

8.94

12.89

1.7

1.8

umol/l

43.5

45.4

0.09

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

269

2.65

12.71

2.4

1.9

mg/l

32.2

29.4

0.12

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

127

3.43

12.34

1.2

1.1

u/l

97.3

75.6

0.73

112

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.78

12.28

1.1

—

(3011985) Renin [Units/volume] in Plasma

263

2.63

12.21

1.6

1.3

mu/l

67.3

45.9

0.41

235

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

299

1951

1.61

12.19

2.9

2.2

u/l

34.8

40.9

1.01

265

1659

(3022145) Colonoscopy Study observation

325

2168

1.57

12.06

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

105

3.66

12.05

1.3

1.1

titre

194.0

92.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

186

2.95

12.05

2.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

3.59

11.73

1.8

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

218

2.75

11.59

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.76

11.56

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

6.71

11.46

1.8

1.6

e6/l

138.9

1826.9

—

(3019977) pH of Arterial blood

100

3.64

11.34

3.0

2.3

7.4

0.08

(3013293) Extractable nuclear Ab [Presence] in Serum

10.05

11.34

1.3

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

3.68

11.23

2.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

125

3.32

11.23

1.2

1.1

u/l

29.8

19.3

0.91

106

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.94

11.21

1.4

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.09

11.13

3.1

5.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.28

11.02

1.3

1.7

—

(3042733) HLA Ab [Presence] in Serum

6.84

11.02

2.8

3.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

238

2.60

10.80

1.1

1.3

pmol/l

252.8

275.2

0.29

194

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.65

10.79

1.4

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

250

2.56

10.78

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

439

2.16

10.75

3.7

2.4

214.2

204.1

0.42

414

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

224

2.63

10.49

1.3

—

24.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

224

2.63

10.49

1.4

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

6.04

10.39

1.3

1.5

ug/l

10.1

10.4

0.07

(3017817) Protein [Mass] in Urine collected for unspecified duration

142

3.06

10.36

2.0

2.1

—

(3020891) Body temperature

155

888

1.79

10.25

6.3

3.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.73

10.24

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.12

10.15

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.12

10.15

1.3

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

118

3.25

10.13

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

3.59

9.93

1.0

1.1

nmol/l

2.4

19.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

209

2.62

9.75

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

432

2.10

9.61

1.2

—

(40761535) Cells panel - Urine sediment

269

1810

1.54

9.55

6.1

3.6

—

(3024928) Oxygen saturation in Venous blood

413

2.12

9.55

5.9

2.5

—

(40761536) Microorganisms panel - Urine sediment

251

1663

1.57

9.54

7.6

4.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

3.40

9.45

2.7

1.5

g/l

0.8

1.0

1.90

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

3.10

9.37

1.6

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.83

9.23

1.6

1.7

pmol/l

17.2

16.5

0.21

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

198

2.61

9.17

1.4

1.3

u/ml

121.8

111.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

6.28

8.99

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.51

8.97

3.1

2.3

—

(3036489) Thrombin time

122

678

1.84

8.94

3.1

1.9

23.0

21.3

1.19

107

601

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

189

2.62

8.93

1.2

u/ml

3.8

4.1

0.06

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.90

8.83

1.1

1.2

—

(3004451) EKG impression Narrative

108

3.18

8.78

1.2

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.36

8.76

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.36

8.76

1.1

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

194

2.56

8.49

1.2

u/ml

1.5

2.3

0.55

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2001

18686

1.36

8.30

29.6

14.1

ml/min/173m2

73.3

71.9

2.22

1739

15038

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.53

8.24

1.2

1.1

ratio

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1733

15865

1.30

8.21

39.9

17.8

14.5

13.8

48.54

1712

15367

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.12

8.18

1.1

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

369

2725

1.42

8.16

4.5

4.8

36.4

34.3

2.45

226

1621

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2091

19679

1.39

8.13

5.1

4.9

mmol/l

5.8

6.0

10.28

1811

17238

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.22

7.94

1.5

1.2

—

(3028433) Virus identified in Specimen by Culture

4.06

7.80

1.0

1.1

—

(3048879) Bone marrow aspiration report

4.06

7.80

1.3

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

267

2.24

7.65

1.2

1.3

nmol/l

—

(3009871) Measles virus Ab [Titer] in Serum

6.69

7.61

1.8

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.11

7.53

1.5

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.93

7.38

1.7

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

227

2.32

7.35

9.2

7.1

mmol/l

6.8

7.5

0.83

191

(3008898) HLA-B27 [Presence]

273

2.19

7.27

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

191

2.43

7.26

1.3

1.1

—

(3000012) Reticulocyte production index

128

2.76

7.12

1.3

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

119

704

1.72

7.12

3.5

3.3

nmol/l

0.9

0.8

0.87

544

(3008536) Aspergillus sp Ab [Presence] in Serum

5.68

7.06

1.0

1.6

—

(40768443) Skin Pathology biopsy report

146

916

1.63

7.01

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

338

2.04

6.99

1.8

1.4

e6/l

8.9

21.8

0.98

253

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

385

2936

1.37

6.98

11.5

7.5

—

(3017569) Oxygen content in Arterial blood

3.31

6.96

2.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

339

2.03

6.93

1.9

1.5

e6/l

230.8

1390.3

1.84

269

(3052592) Norovirus Ag [Presence] in Stool

3.71

6.91

1.5

—

(3045424) Erythrocytes [Presence] in Urine

280

2.13

6.85

1.7

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.49

6.78

2.4

1.4

—

(21494434) Karyotype in Bone marrow

167

2.48

6.76

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.64

6.75

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

103

596

1.76

6.68

2.0

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

147

939

1.60

6.57

1.3

—

54.4

—

(3044889) 12 lead EKG panel

1588

14563

1.25

6.44

5.4

4.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.31

6.41

1.3

1.5

umol/l

50.7

127.9

1.85

(40768804) Tissue Pathology biopsy report

962

8366

1.24

6.31

2.4

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.59

6.31

3.5

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.59

6.31

3.5

2.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.21

6.14

2.6

6.7

mg/l

66.9

83.8

0.35

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

3.41

6.14

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

3.41

6.14

2.0

2.4

umol/l

63.8

57.9

0.26

(3020191) Ethanol [Moles/volume] in Serum or Plasma

3.10

6.04

1.2

1.5

promille

0.5

1.0

1.10

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

117

2.67

5.99

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

3.00

5.95

1.2

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

367

1.91

5.90

2.2

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

3.54

5.88

1.8

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

245

2.10

5.79

4.0

4.3

umol/l

327.8

363.1

0.96

208

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.16

5.74

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

366

1.88

5.63

1.3

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

104

2.71

5.59

1.4

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

3.41

5.58

1.2

1.1

—

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

5.26

5.52

1.2

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

585

1.68

5.49

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

140

925

1.54

5.46

2.1

3.1

u/ml

298.5

2014.1

1.42

114

780

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

579

1.68

5.43

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

587

1.68

5.42

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.19

5.31

1.5

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

112

708

1.61

5.29

1.5

1.6

—

(3045414) Leukocytes [Presence] in Urine

129

844

1.56

5.26

2.3

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.86

5.26

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

208

2.14

5.24

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

164

2.28

5.14

1.1

1.4

—

(3011436) Histone Ab [Units/volume] in Serum

4.21

5.09

1.1

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

199

1433

1.42

5.07

3.0

2.6

ml/min/173m2

56.0

58.4

0.35

644

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

238

2.04

5.06

1.7

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

274

2083

1.35

5.04

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.57

5.04

1.9

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.29

5.02

4.0

1.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

166

1159

1.46

4.99

1.1

1.2

iu/ml

78.5

150.3

2.13

406

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

202

2.10

4.81

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2075

19837

1.27

4.81

5.1

5.3

mmol/l

2.6

2.7

11.88

1803

17575

(43055514) Macroprolactin [Presence] in Serum or Plasma

9.03

4.78

1.1

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

104

663

1.59

4.77

5.4

3.5

mmol/l

3.8

0.19

636

(40768441) Liver Pathology biopsy report

132

2.37

4.74

2.0

1.1

—

(4268621)

126

2.40

4.73

2.4

2.1

—

(3024471) HLA-A [Type]

3.95

4.71

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

473

1.69

4.64

2.5

2.8

u/ml

195.4

911.7

0.68

424

(3022621) pH of Urine by Test strip

198

1449

1.40

4.62

5.5

3.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.62

4.56

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

283

1.89

4.56

1.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

349

2786

1.29

4.56

2.9

4.0

ug/l

10.9

23.1

1.05

294

2277

(3051593) INR in Capillary blood by Coagulation assay

129

2.34

4.50

11.7

15.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2015

19237

1.25

4.47

4.6

mmol/l

4.7

2.68

1749

17044

(3044290) Cell count panel - Cerebral spinal fluid

314

1.83

4.46

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

271

1.90

4.46

1.6

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.57

4.38

1.5

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.73

4.36

1.0

1.1

iu/ml

654.6

144.4

1.18

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1923

18287

1.23

4.32

4.1

mmol/l

1.2

1.3

0.96

1649

15858

(3012516) Albumin [Mass/volume] in Urine

709

6166

1.21

4.28

3.4

3.0

mg/l

1078.2

287.4

1.96

425

3427

(3024522) Salmonella sp identified in Specimen by Organism specific culture

268

1.88

4.27

1.6

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

102

2.47

4.21

1.6

1.3

u/l

63.2

48.6

0.57

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.62

4.20

1.7

1.3

ng/l

107.8

95.8

0.15

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

343

1.77

4.18

1.1

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

263

1.88

4.18

1.6

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.94

4.16

3.1

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

853

0.55

4.08

1.7

—

(4015189)

3.03

3.96

3.3

2.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

261

1.86

3.95

1.6

1.4

—

(40757373) Influenza virus identified in Isolate

3.14

3.93

1.9

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.65

3.92

1.4

1.2

mmol/l

1.4

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.27

3.90

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

462

5449

0.81

3.88

3.3

3.2

—

(3051611) Lipemic interference index of Serum or Plasma

271

1.82

3.83

3.6

2.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

139

2.17

3.83

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.81

3.80

1.3

1.2

—

(4306422)

194

1.97

3.78

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

201

1.96

3.77

1.4

1.2

—

(21494755) Public health laboratory ask at order entry panel

626

0.50

3.75

1.2

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.58

3.71

1.9

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

115

2.27

3.71

1.3

1.6

umol/l

13.2

12.5

0.17

106

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1987

19040

1.21

3.70

4.6

mmol/l

1.6

4.30

1723

16751

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

189

1.97

3.68

1.2

1.3

u/l

227.4

299.4

0.51

174

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.62

3.64

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.62

3.64

1.2

1.0

—

(40768446) Kidney Pathology biopsy report

3.26

3.62

1.8

1.4

—

(4027681)

2.75

3.58

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

263

1.80

3.56

1.6

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

7.80

3.56

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

178

1.98

3.53

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

264

1.80

3.52

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

347

1.69

3.50

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

740

6564

1.18

3.48

4.0

3.7

mg/mmol

17.6

8.4

2.16

427

3685

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.84

3.35

1.7

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.25

3.34

1.1

2.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

175

1.96

3.34

1.5

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

141

2.07

3.32

1.1

—

67.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

109

2.21

3.25

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

184

1.92

3.24

1.2

1.1

u/ml

5.8

2.3

—

(3024932) HLA-DR beta [Type]

3.34

3.19

1.0

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.35

3.19

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

513

0.50

3.18

1.5

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.32

3.17

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

321

1.67

3.09

1.4

g/l

25.9

31.3

1.90

278

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.85

3.02

1.0

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

133

2.04

3.01

2.9

2.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.30

2.99

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.36

2.98

1.2

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

2.36

2.98

1.1

mg/l

298.1

270.6

0.19

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

562

0.55

2.92

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.40

2.87

2.6

2.0

umol/l

17.9

19.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.40

2.87

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

2.30

2.84

1.2

1.1

mg/l

53.2

34.7

0.41

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.92

2.77

1.3

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.23

2.77

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.27

2.77

2.7

3.7

—

(3030313) Adrenal Ab [Titer] in Serum

8.35

2.75

1.0

—

(3001729) Color of Synovial fluid

8.35

2.75

2.4

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

8.35

2.75

1.2

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.72

2.71

1.2

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

576

1.46

2.71

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.15

2.70

1.1

1.3

u/l

148.7

435.8

1.30

(3045716) Anion gap in Serum or Plasma

2.24

2.70

2.2

mmol/l

9.6

9.2

—

(3011648) Oxygen content in Venous blood

146

1.93

2.70

1.3

1.8

9.3

10.3

0.52

146

(4024509)

249

1.70

2.69

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.76

2.67

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

863

1.36

2.57

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

7.15

2.55

2.0

2.4

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

7.15

2.55

2.0

2.4

mg/l

27.9

13.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.74

2.54

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

104

762

1.38

2.53

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.61

2.53

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

143

1.90

2.51

1.1

95.7

95.5

0.01

132

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

143

1.90

2.51

1.4

1.2

u/l

9.8

9.6

0.03

128

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.28

2.51

1.2

1.1

u/l

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

286

1.62

2.49

1.4

e6/l

3343.0

1831.4

0.31

200

(44806071)

3.82

2.46

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.82

2.46

1.5

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.82

2.46

1.5

2.0

—

(4035726)

259

2156

1.22

2.41

1.6

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

289

1.60

2.40

1.5

1.3

iu/l

43.0

42.8

0.01

246

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

212

1.71

2.39

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.76

2.37

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

2.42

2.37

4.0

4.3

53.0

53.7

0.03

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.62

2.36

1.0

1.1

miu/ml

1537.5

1686.7

0.17

(44816559) Phosphatidylethanol [Mass/volume] in Blood

208

1.69

2.27

1.4

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.49

2.27

2.3

2.5

—

(3000764) Benzodiazepines [Presence] in Urine

127

1.90

2.26

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

149

1.82

2.24

1.0

ng/l

288.5

373.2

1.16

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.56

2.21

1.0

—

(3028300) Cannabinoids [Presence] in Urine

128

1.88

2.21

1.1

1.3

—

(3012441) Differential panel - Pleural fluid

233

1.64

2.20

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.78

2.20

1.0

1.5

98.6

83.6

—

(3034426) Prothrombin time (PT)

2.51

2.18

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.03

2.16

1.1

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.30

2.14

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

152

1.78

2.12

1.0

ng/l

781.2

678.7

0.33

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

152

1.78

2.12

1.0

ng/l

34.1

51.8

1.84

100

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.71

2.10

1.0

1.1

98.8

76.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.57

2.09

1.0

1.1

u/ml

0.2

0.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.51

2.05

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.51

2.05

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

673

0.66

2.03

1.5

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.08

2.01

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.08

2.01

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.08

2.01

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

3.08

2.01

1.0

—

(3002256) Pathology report gross observation

308

2657

1.18

1.99

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.34

1.96

1.1

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.03

1.95

1.2

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.95

2.7

1.7

—

63.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.36

1.95

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.97

1.93

1.0

—

(3003694) ABO and Rh group [Type] in Blood

510

4582

1.14

1.93

1.4

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.06

1.91

2.3

2.7

umol/l

30.8

29.6

—

(3011288) Drugs identified in Urine by Screen method

2.06

1.91

1.2

1.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.06

1.91

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

128

1.80

1.89

1.1

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

158

1.72

1.89

1.7

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

1.88

0.0

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

2.16

1.88

1.1

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.19

1.88

1.0

—

(3016879) Cocaine [Presence] in Urine

114

1.85

1.87

1.1

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.54

1.83

1.3

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

3.54

1.83

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.27

1.80

1.0

1.1

ng/l

52.2

643.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.74

4.8

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

201

1.60

1.74

1.2

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.85

1.71

1.0

1.4

mmol/l

—

(4034850)

700

1.31

1.71

16.4

9.9

—

(3035880) pH of Pleural fluid

111

1.81

1.68

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.39

1.67

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

104

1.83

1.67

2.3

1.3

nmol/l

0.2

—

(3045788) Cell count panel - Pleural fluid

228

1.54

1.65

1.5

—

(3051651) Icteric interference index of Serum or Plasma

142

1.70

1.64

4.3

3.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.03

1.64

1.8

1.5

g/l

12.3

13.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.25

1.63

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

121

1.74

1.58

1.6

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

171

1432

1.21

1.58

1.2

—

(40765096) Chromosome analysis panel by Banding

2.21

1.57

1.3

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

143

1720

0.82

1.51

1.5

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.86

1.50

17.2

9.7

mmol/l

5.1

5.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.92

1.43

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

125

1.69

1.43

1.1

1.3

—

(3005570) Glucose [Moles/volume] in Urine

254

1.46

1.40

2.0

1.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.42

1.39

1.3

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

258

1.44

1.31

1.3

1.4

e6/l

179854.5

60627.5

0.30

144

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.50

1.30

3.8

7.8

—

(4198724)

2.50

1.30

1.0

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

387

1.35

1.28

3.2

2.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.29

1.27

1.4

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.29

1.27

1.3

nmol/l

196.0

90.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

178

1.52

1.26

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.63

1.21

1.4

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.75

1.19

1.3

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

485

0.72

1.16

4.0

1.7

mg/l

2.8

3.9

0.43

357

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.34

1.12

1.1

1.2

—

(3006270) Folate [Moles/volume] in Blood

225

1.43

1.12

1.2

nmol/l

260.2

348.1

1.95

174

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.90

1.12

1.0

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

581

5422

1.09

1.11

1.7

1.6

mmol/l

1.3

0.36

491

4461

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.78

1.10

2.2

2.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

316

0.66

1.09

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.38

1.09

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.38

1.09

1.0

1.1

mg/g

5.7

7.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.38

1.09

2.2

7.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

1.76

1.06

1.1

1.3

59.0

66.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.76

1.06

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.12

1.05

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.28

1.03

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

239

1.39

1.00

1.2

miu/ml

91.6

228.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.00

1.00

4.7

8.3

—

(3016750) Collection duration of Urine

107

1.59

0.99

1.6

1.9

min

485.7

501.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

485

1.26

0.99

6.1

3.4

mg/l

21.3

29.5

1.78

302

(3023383) Lactate [Moles/volume] in Pleural fluid

1.81

0.98

1.5

1.2

mmol/l

3.6

3.0

0.21

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.18

0.98

1.6

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.18

0.98

1.6

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.18

0.98

1.6

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.95

0.97

1.0

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.95

0.97

1.7

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

157

1.47

0.96

1.4

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

208

1.40

0.94

1.0

1.1

—

29.5

—

(4212803)

2.23

0.93

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

717

1.21

0.92

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.73

0.92

1.1

—

(40768806) Pleura Pathology biopsy report

252

1.35

0.92

1.3

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

171

0.58

0.91

1.1

1.2

mmol/l

8.2

8.0

—

114

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

350

1.29

0.89

1.7

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

169

1.42

0.87

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.86

0.87

1.1

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.86

0.87

1.0

1.2

—

(4094501)

492

0.77

0.86

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

153

1.44

0.85

2.4

1.6

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.88

0.81

1.0

2.3

iu/ml

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.67

0.78

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

1.67

0.78

1.2

1.1

nmol/l

126.2

127.9

0.05

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.78

0.0

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

124

0.56

0.77

1.3

—

(40768793) Breast Pathology biopsy report

831

0.84

0.75

1.4

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.60

0.75

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

0.74

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

186

1684

1.11

0.71

3.7

4.5

u/ml

40.1

84.1

3.64

179

1610

(3003338) MCHC [Mass/volume]

1636

16041

1.06

0.68

42.9

19.3

g/l

327.8

330.2

18.88

1624

15847

(44806420)

0.54

0.67

1.6

2.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.79

0.66

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

162

1.36

0.66

1.6

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

197

1.32

0.65

1.6

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.73

0.64

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.73

0.64

2.2

9.1

—

(3014051) Protein [Presence] in Urine by Test strip

478

1.20

0.63

2.6

2.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.67

0.61

1.6

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

106

938

1.14

0.61

4.9

ug/l

2.3

3.1

0.46

801

(3020491) Glucose [Moles/volume] in Blood

139

1.37

0.60

1.7

2.2

mmol/l

9.4

7.0

0.56

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

122

1.40

0.60

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

122

1.40

0.60

1.4

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.72

0.57

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

106

1.42

0.57

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1.43

0.56

1.2

1.7

u/l

22.4

54.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

133

1.36

0.55

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

182

0.71

0.54

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

405

1.19

0.53

1.8

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

117

1.37

0.52

5.4

5.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

225

0.75

0.51

1.1

iu/ml

24.6

1111.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.46

0.46

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.43

0.46

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.37

0.44

1.7

1.3

—

(3033799) Differential panel - Peritoneal fluid

1.37

0.40

4.3

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.43

0.39

1.0

1.1

—

(1002224) Polysomnography panel

419

0.86

0.37

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.32

0.37

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

224

0.80

0.36

1.6

1.7

—

(3000330) Specific gravity of Urine by Test strip

140

1305

1.08

0.35

6.0

4.0

—

(3015183) Erythrocyte sedimentation rate

1.31

0.33

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

538

0.89

0.31

2.6

2.9

ug/l

0.5

0.8

3.50

355

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.23

0.29

1.1

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

766

1.09

0.28

7.8

4.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

130

1.23

0.28

1.2

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

270

1.15

0.28

1.2

1.4

—

(3044007) Cell count panel - Peritoneal fluid

0.73

0.24

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

342

3518

0.97

0.21

1.4

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

750

0.93

0.21

4.1

4.3

21.0

21.6

0.09

365

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

335

0.89

0.21

1.2

1.5

nmol/l

0.8

0.20

274

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.20

0.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.17

0.17

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.14

0.16

6.6

1.6

ug/l

3.6

2.4

—

(3006462) Nitrate [Presence] in Urine

102

1.18

0.15

5.7

2.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

131

1.15

0.14

1.2

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

459

0.94

0.13

2.4

2.3

ug/min

157.1

83.2

0.56

260

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

404

1.07

0.12

1.4

—

(3004775) Volume in Urine collected for unspecified duration

163

1.11

0.10

1.7

2.2

728.6

586.5

—

101

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.0

1.1

—

(4146454)

237

0.93

0.09

3.0

2.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.81

0.07

1.5

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

206

1.07

0.07

2.0

2.3

u/field

2.0

3.2

—

(44813793)

0.86

0.06

1.0

—

(4281824)

405

0.96

0.05

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

199

1.06

0.04

2.8

2.5

mg/l

28.1

21.1

0.13

131

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.10

0.04

10.8

2.9

13.8

13.3

—

(4211845)

113

1.06

0.01

5.7

2.7

—

(40768795) Lymph node Pathology biopsy report

231

1.00

0.00

1.4

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

146

1.03

0.00

1.2

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

4.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.87

0.00

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.98

0.00

1.0

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1700.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

8.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.96

0.00

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.0

6.4

—

42.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.0

—

4.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

15.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.8

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.6

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.00

0.00

1.1

1.4

—

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint OSTEOPOROSIS_FRACTURE_FG and mortality.

Females

Parameter	HR [95% CI]	p-value
OSTEOPOROSIS_FRACTURE_FG	1.77 [1.59, 1.97]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.027

During the follow-up period (1.1.1998 — 31.12.2019), 8523 out of 17159 females with OSTEOPOROSIS_FRACTURE_FG died.

Males

Parameter	HR [95% CI]	p-value
OSTEOPOROSIS_FRACTURE_FG	4.601 [3.34, 6.34]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 329 out of 649 males with OSTEOPOROSIS_FRACTURE_FG died.

Mortality risk

Mortality risk for people of age

years, who have OSTEOPOROSIS_FRACTURE_FG.

N-year risk	Females	Males
1	0.094%	0.95%
5	0.856%	5.507%
10	2.284%	13.243%
15	4.261%	23.395%
20	7.661%	36.97%

Relationships between endpoints

↥

Index endpoint: OSTEOPOROSIS_FRACTURE_FG – Osteoporosis with pathological fracture (FG)

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Osteoporosis with pathological fracture (FG)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints